FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2114927900> ?p ?o ?g. }

• W2114927900 endingPage "593" @default.
• W2114927900 startingPage "585" @default.
• W2114927900 abstract "Epidemiologic and biochemical evidence suggest a role of statins and angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) as anti-neoplastic agents. This study was designed to evaluate the association between the use of these agents and the risk of breast cancer recurrence.We reviewed the medical records of patients treated for stage II/III breast cancer between 1999 and 2005. Statin and ACE-inhibitors/ARB users were defined as patients who took these medications for at least 6 months in no evidence of disease (NED) stage after the initial diagnosis. The primary outcome was disease-free survival and the secondary was overall survival. The Kaplan-Meier and Cox proportional hazard models were used.A total of 703 patients were included. The median and maximal of follow up was 55 and 118 months, respectively. A total of 168 patients used ACE-inhibitors/ARBs, 156 patients used statins, and 81 used both. Univariate analysis showed significant reduction in breast cancer recurrence among patients who used ACE-inhibitors/ARBs (hazard ratio (HR) = 0.57; 95% CI: 0.37-0.89; p = .013) or statins (HR = 0.43; 95% CI: 0.26-0.70; p < .001). After adjusting for multiple variables, the use of ACE-inhibitors/ARBs (HR = 0.49; 95% CI: 0.31-0.76; p = .002) and statins (HR = 0.40; 95% CI: 0.24-0.67; p < .001) remained significant and an additive effect was found on those who used both drugs (HR = 0.30 95% CI: 0.15-0.61; p = .001). No association was found regarding overall survival.The use of ACE-inhibitors/ARBs, statins, and the combination of both were all associated with a reduced risk of breast cancer recurrence. This observation should prompt further exploration." @default.
• W2114927900 created "2016-06-24" @default.
• W2114927900 creator A5003927564 @default.
• W2114927900 creator A5004091349 @default.
• W2114927900 creator A5013963892 @default.
• W2114927900 creator A5026436194 @default.
• W2114927900 creator A5038507075 @default.
• W2114927900 creator A5081588858 @default.
• W2114927900 creator A5081885325 @default.
• W2114927900 date "2011-09-21" @default.
• W2114927900 modified "2023-10-01" @default.
• W2114927900 title "Reduced Risk of Breast Cancer Recurrence in Patients Using ACE Inhibitors, ARBs, and/or Statins" @default.
• W2114927900 cites W1726054188 @default.
• W2114927900 cites W1964088193 @default.
• W2114927900 cites W1965734230 @default.
• W2114927900 cites W1966383174 @default.
• W2114927900 cites W1967640779 @default.
• W2114927900 cites W1970784772 @default.
• W2114927900 cites W1971736487 @default.
• W2114927900 cites W1980641014 @default.
• W2114927900 cites W1982852026 @default.
• W2114927900 cites W1993511209 @default.
• W2114927900 cites W1996531946 @default.
• W2114927900 cites W2008506756 @default.
• W2114927900 cites W2010430961 @default.
• W2114927900 cites W2027819282 @default.
• W2114927900 cites W2028070565 @default.
• W2114927900 cites W2036427463 @default.
• W2114927900 cites W2037877663 @default.
• W2114927900 cites W2052049585 @default.
• W2114927900 cites W2053713685 @default.
• W2114927900 cites W2054045500 @default.
• W2114927900 cites W2060287969 @default.
• W2114927900 cites W2067533776 @default.
• W2114927900 cites W2070168457 @default.
• W2114927900 cites W2070815046 @default.
• W2114927900 cites W2072184670 @default.
• W2114927900 cites W2085686527 @default.
• W2114927900 cites W2100163003 @default.
• W2114927900 cites W2101605510 @default.
• W2114927900 cites W2103609668 @default.
• W2114927900 cites W2113914595 @default.
• W2114927900 cites W2114120215 @default.
• W2114927900 cites W2118777546 @default.
• W2114927900 cites W2119562899 @default.
• W2114927900 cites W2127267056 @default.
• W2114927900 cites W2128402540 @default.
• W2114927900 cites W2129732555 @default.
• W2114927900 cites W2132434084 @default.
• W2114927900 cites W2141347342 @default.
• W2114927900 cites W2141570734 @default.
• W2114927900 cites W2148096512 @default.
• W2114927900 cites W2148551844 @default.
• W2114927900 cites W2156988984 @default.
• W2114927900 cites W2159444131 @default.
• W2114927900 cites W2166623085 @default.
• W2114927900 cites W2320173689 @default.
• W2114927900 doi "https://doi.org/10.3109/07357907.2011.616252" @default.
• W2114927900 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21936625" @default.
• W2114927900 hasPublicationYear "2011" @default.
• W2114927900 type Work @default.
• W2114927900 sameAs 2114927900 @default.
• W2114927900 citedByCount "148" @default.
• W2114927900 countsByYear W21149279002012 @default.
• W2114927900 countsByYear W21149279002013 @default.
• W2114927900 countsByYear W21149279002014 @default.
• W2114927900 countsByYear W21149279002015 @default.
• W2114927900 countsByYear W21149279002016 @default.
• W2114927900 countsByYear W21149279002017 @default.
• W2114927900 countsByYear W21149279002018 @default.
• W2114927900 countsByYear W21149279002019 @default.
• W2114927900 countsByYear W21149279002020 @default.
• W2114927900 countsByYear W21149279002021 @default.
• W2114927900 countsByYear W21149279002022 @default.
• W2114927900 countsByYear W21149279002023 @default.
• W2114927900 crossrefType "journal-article" @default.
• W2114927900 hasAuthorship W2114927900A5003927564 @default.
• W2114927900 hasAuthorship W2114927900A5004091349 @default.
• W2114927900 hasAuthorship W2114927900A5013963892 @default.
• W2114927900 hasAuthorship W2114927900A5026436194 @default.
• W2114927900 hasAuthorship W2114927900A5038507075 @default.
• W2114927900 hasAuthorship W2114927900A5081588858 @default.
• W2114927900 hasAuthorship W2114927900A5081885325 @default.
• W2114927900 hasConcept C121608353 @default.
• W2114927900 hasConcept C126322002 @default.
• W2114927900 hasConcept C143998085 @default.
• W2114927900 hasConcept C144301174 @default.
• W2114927900 hasConcept C207103383 @default.
• W2114927900 hasConcept C27016395 @default.
• W2114927900 hasConcept C2776839432 @default.
• W2114927900 hasConcept C2779668873 @default.
• W2114927900 hasConcept C2910553456 @default.
• W2114927900 hasConcept C38180746 @default.
• W2114927900 hasConcept C44249647 @default.
• W2114927900 hasConcept C50382708 @default.
• W2114927900 hasConcept C530470458 @default.
• W2114927900 hasConcept C71924100 @default.
• W2114927900 hasConcept C84393581 @default.

• next